AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Transaction in Own Shares Aug 17, 2022

4932_rns_2022-08-17_b8d703b1-13a6-4732-82c0-7cde531bcf2a.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2413W

PureTech Health PLC

17 August 2022

17 August 2022

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase: 16 August 2022
Number of ordinary shares purchased: 12,947
Highest price paid per share: 242.50p
Lowest price paid per share: 241.00p
Volume weighted average price paid per share: 242.34p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 4,369,136 ordinary shares in treasury and has 284,320,314 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 284,320,314, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders.

This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

[email protected]

Individual Transactions

Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
16/08/2022 11:21:34 5 241.5 XLON 00313214401TRLO1.1.1
16/08/2022 11:21:34 5 241.5 TRQX 00313214400TRLO1.1.1
16/08/2022 11:18:20 61 242 CHIX 00313214029TRLO1.1.1
16/08/2022 11:17:32 42 242.5 BATE 00313213954TRLO1.1.1
16/08/2022 11:17:32 42 242.5 BATE 00313213953TRLO1.1.1
16/08/2022 11:16:17 104 241.5 XLON 00313213808TRLO1.1.1
16/08/2022 11:16:17 56 242 CHIX 00313213807TRLO1.1.1
16/08/2022 11:01:00 15 242.5 BATE 00313211880TRLO1.1.1
16/08/2022 11:00:59 34 242.5 BATE 00313211878TRLO1.1.1
16/08/2022 11:00:58 5 241.5 TRQX 00313211876TRLO1.1.1
16/08/2022 11:00:58 410 241.5 XLON 00313211875TRLO1.1.1
16/08/2022 11:00:58 30 242 AQXE 00313211874TRLO1.1.1
16/08/2022 11:00:58 24 242.5 AQXE 00313211873TRLO1.1.1
16/08/2022 11:00:57 60 242 CHIX 00313211872TRLO1.1.1
16/08/2022 11:00:57 1 242 TRQX 00313211870TRLO1.1.1
16/08/2022 11:00:57 2 242 TRQX 00313211869TRLO1.1.1
16/08/2022 11:00:57 54 242 CHIX 00313211871TRLO1.1.1
16/08/2022 11:00:57 2 242 TRQX 00313211868TRLO1.1.1
16/08/2022 11:00:57 476 242 XLON 00313211867TRLO1.1.1
16/08/2022 11:00:57 476 242.5 XLON 00313211866TRLO1.1.1
16/08/2022 10:56:15 370 242 XLON 00313210802TRLO1.1.1
16/08/2022 10:54:24 6 242 TRQX 00313210345TRLO1.1.1
16/08/2022 10:54:24 50 242 CHIX 00313210344TRLO1.1.1
16/08/2022 10:54:24 428 242.5 XLON 00313210343TRLO1.1.1
16/08/2022 10:54:24 445 242.5 XLON 00313210342TRLO1.1.1
16/08/2022 10:54:24 489 242.5 XLON 00313210341TRLO1.1.1
16/08/2022 10:54:24 435 242.5 XLON 00313210340TRLO1.1.1
16/08/2022 10:54:24 441 242.5 XLON 00313210339TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210337TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210338TRLO1.1.1
16/08/2022 10:54:24 414 242.5 XLON 00313210335TRLO1.1.1
16/08/2022 10:54:24 517 242.5 XLON 00313210336TRLO1.1.1
16/08/2022 10:54:24 482 242.5 XLON 00313210332TRLO1.1.1
16/08/2022 10:54:24 416 242.5 XLON 00313210334TRLO1.1.1
16/08/2022 10:54:24 450 242.5 XLON 00313210333TRLO1.1.1
16/08/2022 10:54:24 59 242.5 CHIX 00313210330TRLO1.1.1
16/08/2022 10:54:24 482 242.5 XLON 00313210331TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210329TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210328TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210326TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210327TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210325TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210324TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210322TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210323TRLO1.1.1
16/08/2022 10:54:24 58 242.5 CHIX 00313210320TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210321TRLO1.1.1
16/08/2022 10:54:24 58 242.5 CHIX 00313210319TRLO1.1.1
16/08/2022 10:54:24 57 242.5 CHIX 00313210318TRLO1.1.1
16/08/2022 10:54:24 46 242.5 BATE 00313210317TRLO1.1.1
16/08/2022 10:54:24 49 242.5 BATE 00313210316TRLO1.1.1
16/08/2022 10:54:24 49 242.5 BATE 00313210314TRLO1.1.1
16/08/2022 10:54:24 49 242.5 BATE 00313210315TRLO1.1.1
16/08/2022 10:54:24 50 242.5 BATE 00313210313TRLO1.1.1
16/08/2022 10:54:24 46 242.5 BATE 00313210312TRLO1.1.1
16/08/2022 10:54:24 5 242.5 TRQX 00313210311TRLO1.1.1
16/08/2022 10:54:24 59 242.5 CHIX 00313210309TRLO1.1.1
16/08/2022 10:54:24 45 242.5 TRQX 00313210310TRLO1.1.1
16/08/2022 10:54:24 62 242.5 CHIX 00313210307TRLO1.1.1
16/08/2022 10:54:24 64 242.5 CHIX 00313210308TRLO1.1.1
16/08/2022 10:54:24 52 242.5 CHIX 00313210306TRLO1.1.1
16/08/2022 10:54:24 32 242.5 AQXE 00313210305TRLO1.1.1
16/08/2022 10:54:24 28 242.5 AQXE 00313210304TRLO1.1.1
16/08/2022 10:54:24 31 242.5 AQXE 00313210303TRLO1.1.1
16/08/2022 10:54:24 30 242.5 AQXE 00313210302TRLO1.1.1
16/08/2022 10:54:24 28 242.5 AQXE 00313210300TRLO1.1.1
16/08/2022 10:54:24 30 242.5 AQXE 00313210301TRLO1.1.1
16/08/2022 10:54:24 49 242.5 BATE 00313210298TRLO1.1.1
16/08/2022 10:54:24 4 242.5 TRQX 00313210299TRLO1.1.1
16/08/2022 10:54:24 40 242.5 BATE 00313210296TRLO1.1.1
16/08/2022 10:54:24 51 242.5 BATE 00313210297TRLO1.1.1
16/08/2022 10:54:24 62 242.5 CHIX 00313210294TRLO1.1.1
16/08/2022 10:54:24 41 242.5 BATE 00313210295TRLO1.1.1
16/08/2022 10:54:24 41 242.5 BATE 00313210292TRLO1.1.1
16/08/2022 10:54:24 54 242.5 CHIX 00313210293TRLO1.1.1
16/08/2022 10:54:24 32 242.5 AQXE 00313210291TRLO1.1.1
16/08/2022 10:54:24 28 242.5 AQXE 00313210290TRLO1.1.1
16/08/2022 10:54:24 28 242.5 AQXE 00313210289TRLO1.1.1
16/08/2022 10:54:24 29 242.5 AQXE 00313210287TRLO1.1.1
16/08/2022 10:54:24 30 242.5 AQXE 00313210288TRLO1.1.1
16/08/2022 10:54:24 34 242.5 AQXE 00313210286TRLO1.1.1
16/08/2022 09:50:52 34 242.5 AQXE 00313197392TRLO1.1.1
16/08/2022 09:49:18 46 241.5 BATE 00313197093TRLO1.1.1
16/08/2022 09:49:07 516 242.5 XLON 00313197060TRLO1.1.1
16/08/2022 09:49:07 437 242.5 XLON 00313197061TRLO1.1.1
16/08/2022 09:49:07 57 242.5 CHIX 00313197059TRLO1.1.1
16/08/2022 09:49:07 57 242.5 CHIX 00313197058TRLO1.1.1
16/08/2022 09:49:07 46 242.5 BATE 00313197057TRLO1.1.1
16/08/2022 09:49:07 46 242.5 BATE 00313197056TRLO1.1.1
16/08/2022 09:49:07 29 242.5 AQXE 00313197055TRLO1.1.1
16/08/2022 09:38:57 693 242.5 XLON 00313195531TRLO1.1.1
16/08/2022 09:38:57 65 242.5 CHIX 00313195530TRLO1.1.1
16/08/2022 09:38:57 61 242.5 CHIX 00313195529TRLO1.1.1
16/08/2022 09:38:57 29 242.5 AQXE 00313195528TRLO1.1.1
16/08/2022 09:38:57 46 242.5 BATE 00313195527TRLO1.1.1
16/08/2022 09:38:57 46 242.5 BATE 00313195526TRLO1.1.1
16/08/2022 09:38:57 32 242.5 AQXE 00313195525TRLO1.1.1
16/08/2022 09:18:45 439 242 XLON 00313191509TRLO1.1.1
16/08/2022 09:15:29 64 242.5 CHIX 00313191089TRLO1.1.1
16/08/2022 09:14:32 44 242 BATE 00313190866TRLO1.1.1
16/08/2022 09:14:32 88 242 BATE 00313190865TRLO1.1.1
16/08/2022 09:14:31 32 242 AQXE 00313190863TRLO1.1.1
16/08/2022 09:13:13 468 242 XLON 00313190185TRLO1.1.1
16/08/2022 09:05:46 30 242 AQXE 00313188781TRLO1.1.1
16/08/2022 09:05:39 434 242 XLON 00313188770TRLO1.1.1
16/08/2022 09:05:24 56 242 CHIX 00313188733TRLO1.1.1
16/08/2022 09:01:01 29 242.5 AQXE 00313188009TRLO1.1.1
16/08/2022 08:54:23 76 241 XLON 00313186791TRLO1.1.1
16/08/2022 08:54:09 53 242.5 CHIX 00313186659TRLO1.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFIATAIRLIF

Talk to a Data Expert

Have a question? We'll get back to you promptly.